Last reviewed · How we verify
NCT06613503
Effectiveness of the AI-Supporter in Reducing Urinary Tract Infections
NA trial testing AI-supporter in Incontinence in 60 participants. Currently enrolling.
31 October 2025
Quick facts
| Lead sponsor | China Medical University Hospital |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | health services research |
| Enrollment | 60 |
| Start date | 22 July 2024 |
| Primary completion | 31 October 2025 |
| Estimated completion | 31 October 2025 |
| Sites | 1 location across Taiwan |
Drugs / interventions tested
- AI-supporter
Conditions studied
- Incontinence — all drugs for Incontinence →
- Urinary Tract Infection — all drugs for Urinary Tract Infection →
- Incontinence-associated Dermatitis — all drugs for Incontinence-associated Dermatitis →
- Cost-effectiveness — all drugs for Cost-effectiveness →
Sponsor
China Medical University Hospital
Who can join
20 and older, female only, with Incontinence or Urinary Tract Infection. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The "AI Supporter," an intelligent excretion management robot, leverages artificial intelligence-based vision recognition to autonomously detect and cleanse affected areas, followed by drying and changing the diaper, thereby reducing caregiver strain and enhancing care quality. This study aims to assess the efficacy of the "AI Supporter" in decreasing the incidence of urinary tract infections and incontinence-associated dermatitis among incontinent patients, in addition to exploring its cost-effectiveness. Adopting an experimental (two groups) and longitudinal design, this research utilizes both convenience and random sampling strategies. The study anticipates recruiting 60 female subjects who have been confined to bed for more than three months with urinary and/or fecal incontinence. Participants will intermittently use the AI Supporter over a 14-day period. Measurement tools include routine urine analysis.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06613503
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Incontinence
Currently open trials in the same condition.
- NCT06679621 — A Telehealth Intervention to Increase Patient Preparedness for Surgery in Latinas · NA · recruiting
- NCT06072911 — Continence, Sexual Function, Fitness and the Health of Men After Surgery for Prostate Cancer · NA · recruiting
- NCT05362292 — TReating Incontinence for Underlying Mental and Physical Health · Phase 4 · recruiting
- NCT05437939 — Adverse Outcomes Following Female Genital Fistula Repair · active not recruiting
Other China Medical University Hospital trials
Trials by the same sponsor.
- NCT07525700 — The Effects of Combining Electronic Picture Books With RPG-Based Gamified Learning on Nursing Students' Motivation and L · NA · not yet recruiting
- NCT07463391 — Chinese Classics Recitation Training in Subjective Cognitive Decline · NA · not yet recruiting
- NCT07482189 — Effectiveness and Efficiency of an Upper Limb Active-Passive Exoskeleton Robot in Patients With Frozen Shoulder · NA · not yet recruiting
- NCT07437144 — Exploring the Effects of Shangshou Daoyin Method on Improving Sleep Quality, Quality of Life, and TCM Constitution in Br · NA · not yet recruiting
- NCT07232667 — Digital Technology for Active and Healthy Ageing in Taiwan · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06613503 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by China Medical University Hospital
- Last refreshed: 26 September 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06613503.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing